FBR Adds Senior Analyst to Healthcare Practice

ARLINGTON, Va., Feb. 17, 2015 (GLOBE NEWSWIRE) -- FBR & Co. (Nasdaq:FBRC) (FBR), a leading investment bank serving the middle market, announced the hiring of Christopher S. James, M.D., as Senior Vice President, Senior Research Analyst in its Equity Research Department. Dr. James will be based in New York and will focus on the biotech sector.

"Chris's operational experience, his tenure as a Wall Street analyst, and his medical background give him a unique perspective which will serve our clients well," said David M. Hilal, Senior Managing Director and Director of Research at FBR. "Adding Chris's coverage to our existing platform will provide additional breadth and depth to our healthcare franchise as we continue to deliver quality, value-add research through our proprietary framework - The Debate TM."

Since graduating from the Yale School of Medicine 14 years ago, Dr. James has held various product development positions in biotech companies and has served as an equity healthcare analyst on both the buy and sellside. He is a graduate of Cornell University and holds an M.D. from Yale University. After medical school, he trained in neurosurgery at Weill Cornell-New York Presbyterian Hospital.

FBR & Co. (Nasdaq:FBRC) provides investment banking, merger and acquisition advisory, institutional brokerage, and research services through its subsidiary FBR Capital Markets & Co. FBR focuses capital and financial expertise on the following industry sectors: consumer; diversified industrials; energy & natural resources; financial institutions; healthcare; insurance; real estate; and technology, media & telecom. FBR is headquartered in the Washington, D.C. metropolitan area with offices throughout the United States. For more information, please visit www.fbr.com.

Statements in this release concerning future performance, developments, events, market forecasts, revenues, expenses, earnings, run rates and any other guidance on present or future periods constitute forward-looking statements. These forward-looking statements are subject to a number of factors, risks and uncertainties that might cause actual results to differ materially from stated expectations or current circumstances. These factors include, but are not limited to, the effect of demand for public and private securities offerings, activity in the secondary securities markets, interest rates, the risks associated with merchant banking investments, the realization of gains and losses on principal investments, available technologies, competition for business and personnel, and general economic, political and market conditions. For a discussion of these and other risks and important factors that could affect FBR's future results and financial condition, see "Risk Factors" in Part I, Item 1A and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Part II, Item 7 of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2013; and other items throughout the Company's Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K.

CONTACT: Investors: Bradley J. Wright at 703.312.9678 or bwright@fbr.com Media: Shannon Hawkins at 703.469.1190 or shawkins@fbr.com

Source:FBR & Co.